MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma
Marielle E. Yohe(National Cancer Center), Javed Khan(Kent State University), Ashley Walton(National Institutes of Health), Sivasish Sindiri(National Institutes of Health), Craig J. Thomas(National Institutes of Health), Kristine A. Isanogle(Leidos (United States)), Xiaoling Luo(National Cancer Institute), Jun S. Wei(Center for Cancer Research), Keji Zhao(National Heart Lung and Blood Institute), Arnulfo Mendoza(National Institutes of Health), Elijah F. Edmondson(Leidos (United States)), Simone Difilippantonio(Leidos (United States)), Rajesh Patidar, Hsien-Chao Chou(National Cancer Institute), Christina M. Robinson(Northwestern University), Parirokh Awasthi(Science Applications International Corporation (United States)), Young Song(University of British Columbia), Jin-Qiu Chen(Peking University), Berkley E. Gryder(University School), Donna Butcher(Frederick National Laboratory for Cancer Research), Xiaohu Zhang(Soochow University), Marc Ferrer(National Institute of Biomedical Innovation, Health and Nutrition), Rajarashi Guha(National Center for Advancing Translational Sciences), Jack F. Shern(National Institutes of Health)
Cited by 155
Related Papers
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
The genetic landscape of high-risk neuroblastoma
|Nature Genetics|2013|1.2k